Core Insights - Humanoid Global Holdings Corp. has appointed Dr. Ahad Armin to its Technical Advisory Committee, enhancing its expertise in humanoid robotics and embodied AI [1][3][6] Company Overview - Humanoid Global is a publicly traded investment issuer focused on building a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, providing liquidity and access to an actively managed portfolio [9] Advisory Role - Dr. Armin will advise on mechanical system design, dynamic modeling, and applied robotics to support the company's technical due diligence and portfolio development [4][6] - The advisory agreement with Dr. Armin has a term of twelve months starting from July 28, 2025, with termination rights for either party [7] Dr. Ahad Armin's Background - Dr. Armin has over a decade of experience in robotics, manufacturing, and mechanical simulation, with previous academic roles at various institutions and industry experience in intelligent automation systems and structural simulations [2][5] Stock Options and RSUs - The company has granted Dr. Armin 50,000 incentive stock options at an exercise price of $0.61, vesting quarterly over one year, and 50,000 restricted share units that will vest immediately [8]
Humanoid Global Welcomes Dr. Ahad Armin to its Technical Advisory Committee
Globenewswireยท2025-08-05 11:30